HYALU OTC
EV HYALU SERUM
HYALU ₹1,199 incl. of all taxes
View product
Anti-Pigmentation Evidence 
01 / 04
01 / 04 Anti-Pigmentation
TYRODIN CREAMY LOTION
CANIXA
100ML
₹750 M.R.P.: ₹750 (incl. of all taxes) Free delivery above ₹499
📦
Delivered in 2-3 days across India
Shipped same-day from our clinic pharmacy · tracked
The Science of Anti-Pigmentation
CANIXA TYRODIN CREAMY LOTION (100ML)
Drug Facts
Active Ingredients
AVOBENZONE
⚑ Contains photosensitising ingredient(s) — pair with SPF 50+.
INGREDIENT · ALPHA HYDROXY ACID (AHA), CHEMICAL EXFOLIANT
Glycolic Acid
also known as Glycolic Acid, Hydroxyacetic Acid
Evidence
Function
Chemical exfoliant; may help support skin renewal and surface keratin dissolution
How it works
Glycolic acid functions as a small-molecular-weight alpha hydroxy acid that may help weaken intracellular bonds within the stratum corneum through pH-dependent hydrolysis. Research indicates the ingredient's permeability and efficacy are significantly influenced by pH dynamics, with effectiveness constrained above its pKa of 3.83. Studies suggest glycolic acid may facilitate enhanced exfoliation when formulated with novel delivery systems that optimize ion-pairing and pH stability. The mechanism involves both chemical dissolution of keratin and potential stimulation of dermal turnover at physiologically tolerable concentrations.
⚑ For Indian skin (Fitzpatrick IV–VI)
Glycolic acid carries heightened risk of post-inflammatory hyperpigmentation (PIH) in Fitzpatrick IV-VI skin types, particularly in Indian populations with darker melanin distribution. Kerala's tropical, humid climate and intense UV exposure (high UVA/UVB index) necessitate strict concurrent photoprotection (SPF 50+ PA+++++) and may require lower concentration initiation (4-6%) with extended adaptation periods. Recommended use restricted to evening application with gradual frequency titration (2-3 times weekly initially), avoiding concurrent use during monsoon or high-humidity seasons when occlusion-related reactions increase. Pre-treatment skin barrier assessment is essential; compromised skin warrants deferral. Patients should receive explicit counseling on mandatory sunscreen compliance and discontinuation at first signs of erythema or dyschromia.
Effective concentration
4–15 % w/w (optimal ~8% w/w)
Clinical evidence
Research indicates that chemical exfoliation efficacy of glycolic acid is significantly limited by pH-dependent permeability reduction above the ingredient's pKa of 3.83, constraining formulation development. Studies suggest that novel biphasic delivery systems utilizing ion-pairing mechanisms may help enhance glycolic acid's exfoliating performance through optimization of pH stability and skin penetration. The findings underscore the critical importance of pH formulation in determining glycolic acid efficacy in topical skincare products.
Not specified in abstract Skin Research and Technology. 2026. PubMed →
Pregnancycaution
Photosensitivityyes — use SPF
Pairs well with
Niacinamide · Ceramides · Hyaluronic Acid · Panthenol · Centella Asiatica Extract · Allantoin
Avoid combining with
Retinol and Retinoids · Salicylic Acid and other BHAs (if same application) · Vitamin C (L-Ascorbic Acid) · Strong oxidizing agents
INGREDIENT · SKIN-LIGHTENING AGENT, TYROSINASE INHIBITOR, ANTIOXIDANT
Arbutin
also known as Arbutin, β-Arbutin, Hydroquinone Glucoside
Evidence
Function
May help support melanin regulation and support more even skin tone appearance
How it works
Arbutin research indicates it functions as a competitive inhibitor of tyrosinase, the enzyme central to melanin synthesis. Studies suggest arbutin may work through modulation of the MITF (Microphthalmia-associated transcription factor) pathway to regulate melanogenesis. The compound appears to deliver hydroquinone (HQ) in a controlled manner to melanocytes, potentially reducing direct exposure to free HQ. Research indicates enzymatic stability and metabolic pathway characteristics may influence the duration and safety profile of skin-lightening effects.
⚑ For Indian skin (Fitzpatrick IV–VI)
Arbutin use in Fitzpatrick IV-VI Indian skin requires careful consideration due to increased risk of post-inflammatory hyperpigmentation (PIH) if applied before skin barrier is fully recovered from inflammation or irritation. In Kerala's tropical, humid climate with high UV index and occupational sun exposure patterns, concurrent strict photoprotection (SPF 50+ broad-spectrum, reapplication every 2 hours) is essential to prevent paradoxical darkening or PIH. Patients with darker skin tones show greater melanin density and higher baseline tyrosinase activity; arbutin efficacy may plateau at lower concentrations, and discontinuation may result in rapid repigmentation. Monitor for signs of irritation, sensitization, or unexpected darkening; lower concentrations (2-4%) and longer treatment intervals are recommended for Indian skin. Combination with other depigmenting agents should be approached cautiously to minimize cumulative irritation risk in this population.
Effective concentration
2–10 % w/w (optimal ~2% w/w)
Clinical evidence
Studies indicate that naturally derived arbutin derivatives (6'-O-caffeoylarbutin) may resist hydrolysis to hydroquinone through conjugation and steric effects, demonstrating superior enzymatic stability compared to parent arbutin. Research suggests this improved stability may contribute to prolonged skin-lightening efficacy and reduced toxicity concerns. The derivative appears to operate through MITF pathway modulation in melanogenesis regulation.
Authors not listed Chemistry & Biodiversity. 2026. PubMed →
Research indicates that arbutin formulated in combination with kojic acid within a supramolecular delivery system may demonstrate synergistic inhibition of melanin production pathways. Studies suggest the combination exhibited above 85% antioxidant activity in radical scavenging assays and remained chemically stable for up to 12 weeks under controlled storage. Evidence suggests such multifunctional systems may offer enhanced melanogenesis regulation potential.
Authors not listed Macromolecular Bioscience. 2026. PubMed →
Research indicates that arbutin, when evaluated in keratinocyte-melanocyte co-culture models as a contextual reference agent, may demonstrate a more favorable safety profile compared to certain alternative depigmenting agents. Studies suggest arbutin's in vitro stress signature and inflammatory response metrics warrant continued safety surveillance, particularly regarding leukoderma-related hazard assessment. Evidence indicates comparative safety profiling remains relevant for informing appropriate agent selection in clinical depigmentation protocols.
Authors not listed Molecules (Basel, Switzerland). 2026. PubMed →
Pregnancycaution
Photosensitivityyes — use SPF
Pairs well with
Kojic Acid · Glycolic Acid · Niacinamide · Vitamin C (L-Ascorbic Acid) · Alpha-Lipoic Acid · Retinol
Avoid combining with
Rhododendrol (similar cytotoxicity profile concerns) · High-dose Raspberry Ketone (in vitro data suggests potential for similar stress signatures) · Strong Benzoyl Peroxide formulations (incompatibility/oxidation risk)
INGREDIENT · VITAMIN B COMPLEX, SKIN CONDITIONING AGENT
Niacinamide
also known as Vitamin B3, Nicotinamide
Evidence
Function
Barrier support, melanin transfer inhibition, anti-inflammatory, skin tone regulation
How it works
Niacinamide functions through multiple pathways including inhibition of melanosome transfer from melanocytes to keratinocytes, thereby potentially reducing hyperpigmentation. Research indicates it modulates skin barrier function by supporting ceramide and lipid synthesis, while simultaneously exerting anti-inflammatory effects through NAD+ pathway involvement. Studies suggest niacinamide's transdermal delivery is pH-dependent, with neutral formulation pH (7.4) facilitating approximately twofold greater skin permeation compared to acidic pH, which may enhance its biological activity.
⚑ For Indian skin (Fitzpatrick IV–VI)
Niacinamide demonstrates particular relevance for Fitzpatrick IV-VI skin types, where post-inflammatory hyperpigmentation (PIH) and melasma represent significant clinical concerns, especially in Indian populations with genetic predisposition to melanin dysregulation. In Kerala's tropical climate with high UV exposure, niacinamide's dual mechanism—supporting barrier integrity against environmental stressors while inhibiting melanin transfer—offers protective benefits without photosensitization risk. Research indicates that niacinamide formulations optimized at neutral pH may enhance efficacy in darker skin phototypes where enhanced permeation facilitates superior melanin transfer inhibition, making it particularly suitable for Indian dermatological practice where melasma prevalence ranges from 8-40% in certain populations. Local humidity and heat may increase transepidermal water loss in tropical settings; niacinamide's barrier-strengthening properties may provide compensatory protection.
Effective concentration
2–10 %w/w (optimal ~4%w/w)
Clinical evidence
Large database analysis examining niacinamide's potential role in skin cancer prevention through supplementation.
Not specified in abstract provided Journal of the American Academy of Dermatology. 2026. PubMed →
Research indicates that neutral pH (7.4) formulations increase niacinamide skin permeation approximately twofold compared to acidic pH (5.0), with corresponding changes in stratum corneum electrical properties facilitating enhanced transdermal delivery. Studies employed Franz cell diffusion experiments and electrical impedance spectroscopy using human skin models to characterize pH-dependent permeation mechanisms.
Not specified in abstract provided Scientific Reports. 2026. PubMed →
Research indicates that dissolving microneedle patches containing niacinamide exhibit greater skin-lightening effects than traditional topical formulations for treating melasma and post-inflammatory hyperpigmentation. Clinical studies have validated safety and efficacy with minimal adverse effects when using advanced transdermal delivery systems.
Not specified in abstract provided Recent Advances in Drug Delivery and Formulation. 2026. PubMed →
Systematic umbrella review evaluating nutritional supplements including niacinamide for primary prevention of skin diseases across 9,229 participants, examining preventive effects against ultraviolet radiation-induced skin pathology and other dermatological conditions.
Not specified in abstract provided Preventive Nutrition and Food Science. 2026. PubMed →
Research comparing glabridin with niacinamide as recognized inhibitor of melanosome transfer in UVB-irradiated co-culture systems demonstrated complementary mechanisms for reducing melanin transfer from melanocytes to keratinocytes through dendrite suppression pathways.
Not specified in abstract provided Pharmaceuticals (Basel, Switzerland). 2026. PubMed →
Pregnancysafe
Photosensitivityno
Pairs well with
Glabridin · Tranexamic acid · Ceramides · Hyaluronic acid · Panthenol · Zinc compounds
INGREDIENT · DEPIGMENTING AGENT / ANTI-INFLAMMATORY
Tranexamic Acid
also known as Tranexamic Acid, TNXA
Evidence
Function
May help support reduction of hyperpigmentation through modulation of melanogenesis and inflammatory pathways
How it works
Tranexamic acid is suggested to modulate multiple biological pathways involved in pigment production, including inflammatory signaling, hormonal balance, and melanocyte activity. Research indicates it may inhibit plasmin-mediated activation of melanocytes and reduce expression of inflammatory cytokines that drive melanogenesis. Studies suggest the ingredient addresses key hyperpigmentation triggers including inflammation, hormonal imbalance, and environmental pollution-induced oxidative stress.
⚑ For Indian skin (Fitzpatrick IV–VI)
Tranexamic acid has been shown to be particularly relevant for Fitzpatrick skin types III-VI, as research indicates these populations experience higher incidence and severity of post-inflammatory hyperpigmentation and melasma with increased tendency toward relapse. In Kerala's tropical climate with high UV exposure and humidity, topical tranexamic acid may provide enhanced benefit when combined with rigorous photoprotection (SPF 50+ daily application). Clinical evidence suggests tranexamic acid is well-tolerated in darker skin types when formulated appropriately, though individual patch testing is recommended prior to full-face application given the increased risk of contact dermatitis in melanin-rich skin.
Effective concentration
2–5 % w/w (optimal ~5% w/w)
Clinical evidence
Real-world case series of 5% tranexamic acid serum demonstrated that application after in-office pigment-targeting procedures (non-ablative laser, microneedling, salicylic acid peel) may accelerate improvement in dyspigmentation. Studies suggest the combination approach offered added benefits of improved skin texture and radiance when integrated into comprehensive skincare regimens.
Journal of Drugs in Dermatology Journal of Drugs in Dermatology. 2026. PubMed →
Randomized controlled trial compared microneedling and intradermal injection approaches for tranexamic acid delivery in melasma treatment. Research indicates both delivery methods demonstrated efficacy, though the study highlights melasma's challenge of resistance to treatment and high relapse tendency.
Indian Journal of Dermatology Indian Journal of Dermatology. 2026. PubMed →
Research indicates that melasma in Fitzpatrick skin types III-V demonstrates high relapse rates and chronic persistence. Studies suggest addressing cytokine-driven inflammation and visible light-induced melanogenesis supports rationale for multimodal therapeutic approaches combining topical agents with procedural interventions.
Journal of Cosmetic Dermatology Journal of Cosmetic Dermatology. 2026. PubMed →
Evidence indicates that Fitzpatrick skin types III-VI experience increased risk of post-inflammatory hyperpigmentation with more pronounced dyspigmentation. Research suggests pathophysiology involves complex pathways including UV radiation, local inflammation, and cytokine signaling, highlighting need for prompt management to prevent months-to-years persistence.
Journal of Cutaneous Medicine and Surgery Journal of Cutaneous Medicine and Surgery. 2026. PubMed →
Research indicates that microneedle patches containing tranexamic acid exhibit greater skin-lightening effects than traditional topical formulations. Clinical studies have validated safety and efficacy in reducing melasma and post-inflammatory hyperpigmentation with minimal adverse effects through enhanced transdermal delivery.
Recent Advances in Drug Delivery and Formulation Recent Advances in Drug Delivery and Formulation. 2026. PubMed →
Pregnancycaution
Photosensitivityno
Pairs well with
Niacinamide · Glabridin · Kojic Acid · Hydroquinone · Alpha-hydroxy acids · Salicylic acid · Retinoids
Avoid combining with
High-pH formulations (may reduce stability) · Oxidizing agents (benzoyl peroxide may degrade)
